Latest in Version Doom

Sort by

3 items

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
CNBC - 6h
The 'Invisible Wall' Amplifying China's Population Doom Loop

A two-tier system that has long made workers leave children behind in villages is cutting into birthrates.
The Wall Street Journal - 12h
FDA approves generic version of Novo Nordisk's GLP-1 diabetes drug Victoza

The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.
NBC News - 1d

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions